Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Messenger Ribonucleic Acid Expression in Lymphocytes of Glaucoma Patients

NCT00327509 is registered in ClinicalTrials.gov with University Hospital, Basel, Switzerland as lead sponsor.

NCT NCT00327509
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00327509 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Messenger Ribonucleic Acid Expression in Lymphocytes of Glaucoma Patients
Lead sponsor
University Hospital, Basel, Switzerland
Phase
Observational
Overall status
Completed
Start date
January 31, 2004
Completion date
December 31, 2007
Enrollment
60 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

glaucoma, healthy subjects